We just received data on a new analyst forecast for $F. Barclays gave a rating of 'Equal-Weight' for $F.
$F Analyst Ratings
Wall Street analysts have issued reports on $F in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 05/01/2025
- B of A Securities issued a "Buy" rating on 04/22/2025
- Bernstein issued a "Underperform" rating on 04/09/2025
- Wells Fargo issued a "Underweight" rating on 02/06/2025
To track analyst ratings and price targets for $F, check out Quiver Quantitative's $F forecast page.
$F Price Targets
Multiple analysts have issued price targets for $F recently. We have seen 11 analysts offer price targets for $F in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Dan Levy from Barclays set a target price of $11.0 on 07/16/2025
- Joseph Spak from UBS set a target price of $11.0 on 07/14/2025
- Alexander Potter from Piper Sandler set a target price of $9.0 on 05/22/2025
- Michael Ward from Citigroup set a target price of $11.0 on 05/07/2025
- Mark Delaney from Goldman Sachs set a target price of $10.0 on 05/06/2025
- Ryan Brinkman from JP Morgan set a target price of $12.0 on 05/01/2025
- John Murphy from B of A Securities set a target price of $14.0 on 04/22/2025
$F Congressional Stock Trading
Members of Congress have traded $F stock 23 times in the past 6 months. Of those trades, 15 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $F stock by members of Congress over the last 6 months:
- REPRESENTATIVE TIM MOORE has traded it 16 times. They made 11 purchases worth up to $750,000 on 04/10, 04/09, 04/08, 04/07, 03/31, 03/05, 02/13, 02/10, 02/07, 02/06, 02/04 and 5 sales worth up to $800,000 on 04/15, 03/10, 03/03, 02/05, 01/21.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 04/08 and 1 sale worth up to $15,000 on 02/25.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/12 and 1 sale worth up to $15,000 on 04/01.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 03/31, 01/24 and 1 sale worth up to $15,000 on 02/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$F Insider Trading Activity
$F insiders have traded $F stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $F stock by insiders over the last 6 months:
- ANDREW FRICK (President, Ford Blue & Model e) has made 0 purchases and 2 sales selling 60,000 shares for an estimated $675,000.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$F Hedge Fund Activity
We have seen 753 institutional investors add shares of $F stock to their portfolio, and 758 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 55,576,478 shares (+13.8%) to their portfolio in Q1 2025, for an estimated $557,432,074
- PACER ADVISORS, INC. added 48,378,444 shares (+6915.1%) to their portfolio in Q1 2025, for an estimated $485,235,793
- BLACKROCK, INC. added 25,848,105 shares (+8.8%) to their portfolio in Q1 2025, for an estimated $259,256,493
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 14,602,466 shares (-64.9%) from their portfolio in Q1 2025, for an estimated $146,462,733
- SQUAREPOINT OPS LLC removed 12,943,697 shares (-92.7%) from their portfolio in Q1 2025, for an estimated $129,825,280
- RENAISSANCE TECHNOLOGIES LLC added 12,915,400 shares (+201.0%) to their portfolio in Q1 2025, for an estimated $129,541,461
- TWO SIGMA ADVISERS, LP added 11,549,400 shares (+1849.4%) to their portfolio in Q1 2025, for an estimated $115,840,482
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
